Samsung Commits $1.8 Trillion to Tech and Biopharma Through 2040
1h ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
samsungsemiconductors
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Samsung Group unveiled an investment roadmap totaling approximately 2,500 trillion Korean won ($1.8 trillion) on June 29, 2026. The conglomerate will direct the capital primarily toward its semiconductor and biopharmaceutical businesses through the year 2040. The initiative aims to solidify South Korea’s position in the global technology supply chain. This commitment represents one of the largest corporate investment pledges in history.
The announcement arrives during a period of intense global competition in semiconductor manufacturing. Governments worldwide are implementing massive subsidy programs, such as the US CHIPS Act and the European Chips Act, to secure domestic production capacity. Samsung's plan is a direct response to similar multi-hundred-billion dollar investments announced by rivals TSMC and Intel over the past two years.
South Korea’s government has actively encouraged domestic corporate investment to bolster economic security. The national strategy explicitly links technological sovereignty with long-term economic growth. This state-corporate alignment mirrors industrial policies seen in other major economies aiming for supply chain resilience.
The immediate catalyst is the accelerating race to develop sub-2-nanometer chip fabrication processes and advanced packaging technologies. Control over these next-generation nodes is considered critical for leadership in artificial intelligence, autonomous systems, and high-performance computing. Samsung’s investment timeline is structured to match anticipated demand cycles for these technologies.
The $1.8 trillion commitment is allocated across a 16-year horizon, averaging over $112 billion annually. A significant majority of the capital, approximately 80% or $1.44 trillion, is earmarked for investments within South Korea. The remaining 20% will fund international expansion projects in key markets like the United States and Europe.
The plan includes the construction of five new state-of-the-art semiconductor fabrication plants, or fabs, in a new mega-cluster near Seoul. This cluster is projected to create 180,000 direct and indirect jobs by 2040. Samsung’s capital expenditure for 2025 was approximately $40 billion, indicating a planned substantial ramp-up in spending.
For comparison, Taiwan’s TSMC has guided for capital expenditures of $32-36 billion in 2026. Intel’s multi-year investment plan, partially supported by US government grants, totals over $100 billion but remains smaller in scale. Samsung’s investment dwarfs the annual GDP of many countries, exceeding the 2025 GDP of nations like the Netherlands.
| Metric | Samsung Plan (2025-2040) | TSMC 2026 Guidance | Intel Multi-Year Plan |
|---|---|---|---|
| Total Investment | $1.8 Trillion | $32-36 Billion (Annual) | ~$100 Billion |
| Primary Focus | Semiconductors, Biopharma | Semiconductors | Semiconductors, Foundry |
The scale of this investment is a significant bullish catalyst for global semiconductor equipment suppliers. Companies like ASML, Applied Materials, and Lam Research are positioned to secure enormous supply contracts for advanced lithography and fabrication tools. Orders for these firms could see a sustained boost of 15-25% over the medium term.
Within South Korea, the announcement benefits a network of local suppliers. Firms like Soulbrain Co. (chemicals) and Wonik IPS (facility systems) are direct beneficiaries of the domestic construction boom. The Korean won may experience strengthening pressure from anticipated foreign capital inflows to fund these projects.
A key risk involves the execution of such a vast capital plan amid potential cyclical downturns in the semiconductor industry. High capital intensity could pressure Samsung Electronics' [005930.KS] operating margins if demand for chips softens unexpectedly. The plan also assumes continued government cooperation and regulatory approvals across multiple international jurisdictions.
Investment banks are likely to increase price targets for Samsung Electronics and its affiliate companies. Hedge fund positioning data suggests initial flows into the iShares MSCI South Korea ETF (EWY) and the VanEck Semiconductor ETF (SMH). Short interest is building in smaller, non-Korean memory chip producers who may struggle to compete with the coming capacity glut.
The first major milestone is Samsung Foundry’s detailed roadmap update scheduled for the fourth quarter of 2026. This presentation will specify technology nodes and production timelines for the new fabs. Permitting and construction on the first new facility is expected to begin in early 2027.
Market participants should monitor quarterly earnings calls from key equipment suppliers for forward guidance revisions. ASML’s Q3 2026 earnings on October 15 will be a critical indicator of order book strength related to the Samsung plan. Bond issuance by Samsung affiliates to fund the early stages of the project will test investor appetite for long-duration Korean corporate debt.
Key levels to watch include the USD/KRW exchange rate, which could test support at 1,250 won per dollar on sustained inflows. The Philadelphia Semiconductor Index (SOX) will be a barometer of overall sector sentiment. A sustained break above the 5,200 level would confirm bullish momentum fueled by the capital expenditure cycle.
The massive injection of capital aims to increase production capacity for advanced semiconductors, which could lead to lower prices for end-users over the long term. However, in the short to medium term, prices are more influenced by immediate supply-demand dynamics in specific chip categories like DRAM and NAND flash. The investment is targeted at leading-edge logic chips for AI and data centers, a segment with structurally high demand, potentially mitigating severe price depreciation.
The announcement intensifies the global foundry war, forcing competitors to respond with their own accelerated investment plans to maintain market share. TSMC and Intel will face increased pressure on pricing and technological innovation. This competitive dynamic is a net positive for their customers, including Apple and NVIDIA, who will benefit from more options and potentially better terms. The overall industry capital expenditure ceiling is being raised permanently.
While Samsung is a leader in memory chips, this strategic plan heavily emphasizes expanding its foundry business, which manufactures logic chips for other companies based on their designs. A core objective is to challenge TSMC's dominance in manufacturing advanced processors for smartphones, PCs, and AI accelerators. The biopharmaceutical division, Samsung Biologics, will also receive a substantial portion of the funds to expand its contract drug manufacturing operations.
Samsung's capital commitment resets the scale of competition in global technology manufacturing for the next decade.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Position yourself for the macro moves discussed above
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.